A new model for managing GLP-1 demand, access, outcomes, and cost.
Developed in collaboration with Mayo Clinic to deliver neuro-hormonal cardiometabolic healthcare that is clinically grounded, personalized at every step, and built to last.
01 / Foundation
Clinically grounded healthcare
Built on current evidence and physician oversight, designed around the neuro-hormonal cardiometabolic system rather than a single drug class.
Evidence-firstPhysician-led
02 / Practice
Personalized at every step
Guiding patients through care that reflects their biology, behavior, goals, budget, and lived reality, not a single protocol.
Whole-personAdaptive
03 / Stewardship
Affordable, appropriate, sustainable
Ensuring GLP-1s are used when clinically appropriate, alongside the full range of effective interventions, so plans can carry the cost for the long run.
Cost-awareOutcomes-tracked
Early access
Get in touch.
Tell us a little about your interest in Metriana and we’ll be in touch.
